FDA, Influenza vaccine and Flu season
It's the second such disruption to a federal vaccine advisory panel since Robert F. Kennedy Jr. became the nation’s top health official earlier this month.
The U.S. Food and Drug Administration confirmed today that a meeting of its independent advisory panel to discuss the composition of this year’s flu vaccine had been canceled and that the regulator would instead make recommendations later.
The Food and Drug Administration (FDA) has abruptly cancelled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains.
A meeting of a committee which advises the U.S. Food and Drug Administration on vaccine policy has been canceled, a committee member told Reuters, the second such disruption to a federal vaccine advisory panel since Robert F.
The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza vaccines, an HHS official confirmed Thursday.